Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 2,804 shares at $15.81 ($44K) on 2022-10-15, disclosed to the SEC on 2022-10-18.
Seasonal sale ($44k) by CEO — this insider has traded ACAD in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |